224 related articles for article (PubMed ID: 38270350)
1. Lipid-based nanomedicines for the treatment of bacterial respiratory infections: current state and new perspectives.
Arroyo-Urea EM; Lázaro-Díez M; Garmendia J; Herranz F; González-Paredes A
Nanomedicine (Lond); 2024 Feb; 19(4):325-343. PubMed ID: 38270350
[TBL] [Abstract][Full Text] [Related]
2. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms.
Forier K; Raemdonck K; De Smedt SC; Demeester J; Coenye T; Braeckmans K
J Control Release; 2014 Sep; 190():607-23. PubMed ID: 24794896
[TBL] [Abstract][Full Text] [Related]
3. Combination and nanotechnology based pharmaceutical strategies for combating respiratory bacterial biofilm infections.
Zhang L; Bera H; Wang H; Wang J; Guo Y; Shi C; Cun D; Moser C; Høiby N; Yang M
Int J Pharm; 2022 Mar; 616():121507. PubMed ID: 35085729
[TBL] [Abstract][Full Text] [Related]
4. Pillar[
Jothi Nayaki S; Roja A; Ravindhiran R; Sivarajan K; Arunachalam M; Dhandapani K
ACS Infect Dis; 2024 Apr; 10(4):1080-1096. PubMed ID: 38546344
[TBL] [Abstract][Full Text] [Related]
5. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
Subhaswaraj P; Syed A; Siddhardha B
Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
[TBL] [Abstract][Full Text] [Related]
6. Strategies to Promote the Journey of Nanoparticles Against Biofilm-Associated Infections.
Wang X; Wang D; Lu H; Wang X; Wang X; Su J; Xia G
Small; 2024 Mar; 20(10):e2305988. PubMed ID: 38178276
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic-nanomedicines: facing the challenge of effective treatment of antibiotic-resistant respiratory tract infections.
Ritsema JA; der Weide HV; Te Welscher YM; Goessens WH; van Nostrum CF; Storm G; Bakker-Woudenberg IA; Hays JP
Future Microbiol; 2018 Nov; 13():1683-1692. PubMed ID: 30499686
[TBL] [Abstract][Full Text] [Related]
8. Nanomaterials for alternative antibacterial therapy.
Hemeg HA
Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
[TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive nanoplatforms for antibacterial applications.
Huang Y; Zou L; Wang J; Jin Q; Ji J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1775. PubMed ID: 35142071
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections.
Huang Z; Kłodzińska SN; Wan F; Nielsen HM
Drug Deliv Transl Res; 2021 Aug; 11(4):1634-1654. PubMed ID: 33694082
[TBL] [Abstract][Full Text] [Related]
11. Combination of Cefditoren and
Llamosí M; Sempere J; Coronel P; Gimeno M; Yuste J; Domenech M
Microbiol Spectr; 2022 Dec; 10(6):e0341522. PubMed ID: 36445126
[TBL] [Abstract][Full Text] [Related]
12. Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment.
Colilla M; Vallet-Regí M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203098
[TBL] [Abstract][Full Text] [Related]
13. Bacterial biofilm infections, their resistance to antibiotics therapy and current treatment strategies.
Singh A; Amod A; Pandey P; Bose P; Pingali MS; Shivalkar S; Varadwaj PK; Sahoo AK; Samanta SK
Biomed Mater; 2022 Feb; 17(2):. PubMed ID: 35105823
[TBL] [Abstract][Full Text] [Related]
14. Micro-/Nanorobots in Antimicrobial Applications: Recent Progress, Challenges, and Opportunities.
Zhang Z; Wang L; Chan TKF; Chen Z; Ip M; Chan PKS; Sung JJY; Zhang L
Adv Healthc Mater; 2022 Mar; 11(6):e2101991. PubMed ID: 34907671
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.
Wong JP; DiTullio P; Parkinson S
Future Microbiol; 2015; 10(11):1751-8. PubMed ID: 26597426
[TBL] [Abstract][Full Text] [Related]
16. Nanomaterials for the Treatment of Bacterial Biofilms.
Wang LS; Gupta A; Rotello VM
ACS Infect Dis; 2016 Jan; 2(1):3-4. PubMed ID: 27622944
[TBL] [Abstract][Full Text] [Related]
17. Biofilm-associated infections: antibiotic resistance and novel therapeutic strategies.
Sun F; Qu F; Ling Y; Mao P; Xia P; Chen H; Zhou D
Future Microbiol; 2013 Jul; 8(7):877-86. PubMed ID: 23841634
[TBL] [Abstract][Full Text] [Related]
18. Challenges and strategies in drug delivery systems for treatment of pulmonary infections.
Ho DK; Nichols BLB; Edgar KJ; Murgia X; Loretz B; Lehr CM
Eur J Pharm Biopharm; 2019 Nov; 144():110-124. PubMed ID: 31493510
[TBL] [Abstract][Full Text] [Related]
19. Micro/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents.
Bianchera A; Buttini F; Bettini R
Expert Opin Ther Pat; 2020 Dec; 30(12):983-1000. PubMed ID: 33078643
[TBL] [Abstract][Full Text] [Related]
20. Bacteria in the respiratory tract-how to treat? Or do not treat?
Prat C; Lacoma A
Int J Infect Dis; 2016 Oct; 51():113-122. PubMed ID: 27776777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
